Where Does Combination Therapy With an SGLT2 Inhibitor Plus a DPP-4 Inhibitor Fit in the Management of Type 2 Diabetes?

被引：47

作者：

Abdul-Ghani, Muhammad ^{[1
]}

机构：

[1] Univ Texas Hlth Sci Ctr San Antonio, Div Diabet, San Antonio, TX 78229 USA

来源：

DIABETES CARE | 2015年 / 38卷 / 03期

关键词：

DAPAGLIFLOZIN;

D O I：

10.2337/dc14-2517

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

收藏

页码：373 / 375

页数：3

相关论文

共 13 条

[1]

Novel Hypothesis to Explain Why SGLT2 Inhibitors Inhibit Only 30-50% of Filtered Glucose Load in Humans [J].

Abdul-Ghani, Muhammad A. ;

DeFronzo, Ralph A. ;

Norton, Luke .

DIABETES, 2013, 62 (10) :3324-3328

[2]

Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes [J].

Abdul-Ghani, Muhammad A. ;

Norton, Luke ;

DeFronzo, Ralph A. .

ENDOCRINE REVIEWS, 2011, 32 (04) :515-531

[3]

The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients [J].

Balas, Bogdan ;

Baig, Muhammad R. ;

Watson, Catherine ;

Dunning, Beth E. ;

Ligueros-Saylan, Monica ;

Wang, Yibin ;

He, Yan-Ling ;

Darland, Celia ;

Holst, Jens J. ;

Deacon, Carolyn F. ;

Cusi, Kenneth ;

Mari, Andrea ;

Foley, James E. ;

DeFronzo, Ralph A. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (04) :1249-1255

[4]

Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin [J].

DeFronzo, Ralph A. ;

Lewin, Andrew ;

Patel, Sanjay ;

Liu, Dacheng ;

Kaste, Renee ;

Woerle, Hans J. ;

Broedl, Uli C. .

DIABETES CARE, 2015, 38 (03) :384-393

[5]

From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus [J].

DeFronzo, Ralph A. .

DIABETES, 2009, 58 (04) :773-795

[6]

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients [J].

Ferrannini, Ele ;

Muscelli, Elza ;

Frascerra, Silvia ;

Baldi, Simona ;

Mari, Andrea ;

Heise, Tim ;

Broedl, Uli C. ;

Woerle, Hans-Juergen .

JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (02) :499-508

[7]

Is glycemic control improving in US adults? [J].

Hoerger, Thomas J. ;

Gregg, Edward W. ;

Segel, Joel E. ;

Saaddine, Jinan B. .

DIABETES CARE, 2008, 31 (01) :81-86

[8]

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes [J].

Inzucchi, Silvio E. ;

Bergenstal, Richard M. ;

Buse, John B. ;

Diamant, Michaela ;

Ferrannini, Ele ;

Nauck, Michael ;

Peters, Anne L. ;

Tsapas, Apostolos ;

Wender, Richard ;

Matthews, David R. .

DIABETES CARE, 2015, 38 (01) :140-149

[9]

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production [J].

Merovci, Aurora ;

Solis-Herrera, Carolina ;

Daniele, Giuseppe ;

Eldor, Roy ;

Fiorentino, Teresa Vanessa ;

Tripathy, Devjit ;

Xiong, Juan ;

Perez, Zandra ;

Norton, Luke ;

Abdul-Ghani, Muhammad A. ;

DeFronzo, Ralph A. .

JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (02) :509-514

[10]

The Place of GLP-1-Based Therapy in Diabetes Management: Differences Between DPP-4 Inhibitors and GLP-1 Receptor Agonists [J].

Mize, Dara L. Eckerle ;

Salehi, Marzieh .

CURRENT DIABETES REPORTS, 2013, 13 (03) :307-318